AddictAid Lozenges 2 mg
Natural health product licensed in Canada
- Other names
- Addict Aid 2 mg, Nictotine Lozenges 2 mg
- Licence holder
- CellChem Pharmaceuticals Inc.
- NPN or DIN-HM
- 80123612
- Status
- Active licence
- Licence date
- 22 March 2023
- Revision date
- Not provided
- Form
- Pastille
- Route of administration
- Buccale
- Application type
- Générale (non traditionelle)
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| 3-((2S)-1-méthyl-2-pyrrolidinyl)-pyridine Source : Nicotine polacrilex | 2 mg |
Non-medicinal ingredients
Dioxyde de titane, Sucre, Acide citrique anhydre, Saveur de menthe poivrée, Jaune de quinoléine (E104), Glucose liquide, Bleu FD&C n° 1, (p)-hydroxybenzoate de méthyle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Pastille | minimum: 1 Tous les jours ; maximum: 16 Tous les jours |
| Adultes | minimum: 18 years | 1 Pastille | minimum: 1 Tous les jours ; maximum: 32 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
AddictAid Lozenge can help you stop smoking by reducing withdrawal symptoms. Using AddictAid Lozenge can enable you to reduce the daily number of cigarettes smoked to ease the transition into a smoke-free lifestyle. Although smoking cessation is preferable, the product can also be used in cases when you need to temporarily refrain from smoking, for example, in smoke-free areas, airplanes, etc. or in other situations when you wish to avoid smoking. Product effectiveness is directly related to your motivation to smoking. Consult your pharmacist or doctor regarding the availability of smoking cessation programs in your area for counselling and support.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80123612
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.